Document is current

Article History

Received: 25 March 2025

Accepted: 15 May 2025

First Online: 4 June 2025

Declarations

:

: Not applicable as this study did not involve human or animal subjects.

: Not applicable as this study did not involve human or animal subjects.

: Not applicable as this study did not involve human or animal subjects.

: MJM has received research funding from Bristol-Myers Squibb and travel support from Pierre Fabre.PL has received honoraria for lectures from Blue Earth Diagnostics, and for advisory board participation from Servier.NG has received honoraria for lectures from Blue Earth Diagnostics, for advisory board participation from Telix Pharmaceuticals and Servier, and for consultancy services from Telix Pharmaceuticals.PB has received honoraria for lectures, consultation or advisory board participation from Servier, “Ekspertpanelet” and “Moloklinikken”.JFD received honoraria for lectures from Varian and Ion Beam Applications, and for advisory board participation from Servier.FE has received honoraria and travel support from ZAP Surgical Systems, Inc., and Accuray, Inc., and acknowledges research funding from the German Cancer Aid and Accuray, Inc., all unrelated to the submitted work.JF has received honoraria for lectures, consultation or advisory board participation from Novartis, Seagen, Sanova, Servier.MN received speaker honoraria from Brainlab and Astra Zeneca.AP has received consultancy fees from Servier, unrelated to the submitted work.ER has received honoraria for advisory board from Gilead, Novartis, AstraZeneca and Servier survey and travel grants from Servier, AstraZeneca, Integris, BMS, Roche, Pfizer, Gilead.MS has received consultancy fees from Bracco (paid to institution) and speaker fees from the European School of Radiology (paid to institution).NT has received honoraria for advisory board participation and consultancy services from Telix Pharmaceuticals and receives in kind research support from Curium Pharma.AV has received honoraria for lectures and advisory board participation from Curium, Eisai, General Electrics and Novartis.ELR has received research grants from Bristol Meyers Squibb (BMS), and honoraria for lectures or advisory board participation or consulting from Astra Zeneca, Daiichi, Bayer, Biodexa/Sitoxi, Janssen, Leo Pharma, Pfizer, Pierre Fabre, Roche, Seattle Genetics and Servier.GM has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Brainlab, Accuray, Servier, Astra-Zeneca, Novocure, Pfizer.MW has received research grants from Novartis, Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Anheart, Bayer, Curevac, Medac, Neurosense, Novartis, Novocure, Orbus, Pfizer, Philogen, Roche and Servier. MP has received honoraria for lectures, consultation or advisory board participation from Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CNC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, AstraZeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dohme, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Janssen, Servier, Miltenyi, Boehringer Ingelheim, Telix, Medscape, OncLive, Nerviano Medical Sciences.NLA has received honoraria for lectures, consultation or advisory board participation from ABX, Advanced Accelerator Applications, Carthera, ITM, Medsir, Novartis, OncLive, Servier and Telix Pharmaceuticals, and research funding from Novocure and Telix Pharmaceuticals.All other authors declare that they have no conflict of interest related to the present study.